Adverse Cerebral Cardiovascular Events Associated With Checkpoint Kinase 1 Inhibitors: A Systemic Review. Yang T, Gu J, Du C, Shan T, et al. J Cardiovasc Pharmacol 2021;77:549-556.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang T, Gu J, Du C, Shan T, et al. Adverse Cerebral Cardiovascular Events Associated With Checkpoint Kinase 1 Inhibitors: A Systemic Review. J Cardiovasc Pharmacol 2021;77:549-556.
PMID: 33951693